There’s no doubt Americans are increasingly using weight loss drugs like Ozempic. In fact, it’s been estimated that up to 1.7% of the population has been prescribed a drug containing semaglutide (the active ingredient in Ozempic) so far this year.
And that’s just the beginning of the new trend. Morgan Stanley has predicted that, over the next 10 years, 7% of the U.S. population could be taking these drugs—24 million people possibly consuming 20% fewer calories by, more than likely, cutting high-calorie snacks and fast food out of their diets. Put another way, Americans’ consumption of soda, baked goods, and salty snacks could drop by around 3%, according to Morgan Stanley analysts.
